Literature DB >> 15290922

The inflammatory bowel disease questionnaire: a review of its national validation studies.

A G Pallis1, I A Mouzas, I G Vlachonikolis.   

Abstract

Health-related quality of life (HRQoL) is an important measure of illness perception on the part of the patient. The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for HRQoL assessment in patients with inflammatory bowel diseases (IBDs). This questionnaire has been adapted and validated into several languages and cultural milieus. The aim of this study is to review the methods used by several adaptation studies for assessing the validity and reliability of the adapted IBDQ. A search was made of the Medline database for relevant articles since 1989. Standard validation criteria were used for including studies for further evaluation. The following aspects of the validation procedure were examined: translation, construct validity, reliability, sensitivity to change, and used statistical methods. Nine validation studies of the IBDQ, in England and in non English-speaking countries (Holland, Spain, Korea, Sweden, Greece, and China) were selected. All studies concluded that the adapted instrument was valid and reliable. Only few modifications were proposed. Two studies recommended the split of the four dimensions of the original questionnaire in five. Assessing HRQoL in patients with IBD is an ever-increasing practice, especially in clinical trials. IBDQ was proven to be valid and reliable in several cultural and linguistic milieus when appropriate validation procedures were applied.

Entities:  

Mesh:

Year:  2004        PMID: 15290922     DOI: 10.1097/00054725-200405000-00014

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  20 in total

1.  Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis.

Authors:  L Keefer; T H Taft; J L Kiebles; Z Martinovich; T A Barrett; O S Palsson
Journal:  Aliment Pharmacol Ther       Date:  2013-08-19       Impact factor: 8.171

2.  Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument.

Authors:  Johanna Haapamäki; Risto P Roine; Harri Sintonen; Ulla Turunen; Martti A Färkkilä; Perttu E T Arkkila
Journal:  Qual Life Res       Date:  2010-04-02       Impact factor: 4.147

3.  Inflammatory Bowel Disease Is Not a Contraindication for Bariatric Surgery.

Authors:  Stephanie Aelfers; Ignace M C Janssen; Edo O Aarts; Carolijn Smids; Marcel J Groenen; Frits J Berends
Journal:  Obes Surg       Date:  2018-06       Impact factor: 4.129

Review 4.  Assessing patient reported outcome measures: A practical guide for gastroenterologists.

Authors:  Laith Alrubaiy; Hayley A Hutchings; John G Williams
Journal:  United European Gastroenterol J       Date:  2014-12       Impact factor: 4.623

Review 5.  The use of questionnaires in pediatric inflammatory bowel disease.

Authors:  Cheryl Blank; Galen E Switzer
Journal:  Curr Gastroenterol Rep       Date:  2006-06

Review 6.  Psoriasis: epidemiology, clinical features, and quality of life.

Authors:  R G B Langley; G G Krueger; C E M Griffiths
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

7.  Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.

Authors:  Bijal Surti; Brennan Spiegel; Andrew Ippoliti; Eric A Vasiliauskas; Peter Simpson; David Q Shih; Stephan R Targan; Dermot P B McGovern; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2012-12-19       Impact factor: 3.199

Review 8.  The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.

Authors:  Aaron Yarlas; Stephen Maher; Martha Bayliss; Andrew Lovley; Joseph C Cappelleri; Andrew G Bushmakin; Marco D DiBonaventura
Journal:  J Patient Cent Res Rev       Date:  2020-04-27

9.  Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial).

Authors:  Emma J Eshuis; Willem A Bemelman; Ad A van Bodegraven; Mirjam A G Sprangers; Patrick M M Bossuyt; A W Marc van Milligen de Wit; Rogier M P H Crolla; Djuna L Cahen; Liekele E Oostenbrug; Meindert N Sosef; Annet M C J Voorburg; Paul H P Davids; C Janneke van der Woude; Johan Lange; Rosalie C Mallant; Maarten J Boom; Rob J Lieverse; Edwin S van der Zaag; Martin H M G Houben; Juda Vecht; Robert E G J M Pierik; Theo J M van Ditzhuijsen; Hubert A Prins; Willem A Marsman; Henricus B Stockmann; Menno A Brink; Esther C J Consten; Sjoerd D J van der Werf; Andreas W K S Marinelli; Jeroen M Jansen; Michael F Gerhards; Clemens J M Bolwerk; Laurents P S Stassen; B W Marcel Spanier; Ernst Jan Spillenaar Bilgen; Anne-Marie van Berkel; Huib A Cense; Henk A van Heukelem; Arnold van de Laar; Warner Bruins Slot; Quirijn A Eijsbouts; Nancy A M van Ooteghem; Bart van Wagensveld; Jan M H van den Brande; Anna A W van Geloven; Karien F Bruin; John K Maring; Bas Oldenburg; Richard van Hillegersberg; Dirk J de Jong; Robert Bleichrodt; Donald L van der Peet; Pascal E P Dekkers; T Hauwy Goei; Pieter C F Stokkers
Journal:  BMC Surg       Date:  2008-08-22       Impact factor: 2.102

10.  Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients.

Authors:  Iradj Maleki; Tarang Taghvaei; Maryam Barzin; Kamyar Amin; Alireza Khalilian
Journal:  Caspian J Intern Med       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.